Ignite Creation Date:
2024-05-05 @ 10:07 PM
Last Modification Date:
2024-10-26 @ 10:14 AM
Study NCT ID:
NCT01038284
Status:
COMPLETED
Last Update Posted:
2014-03-17
First Post:
2009-10-22
Brief Title:
Multidisciplinary Collaboration Care in Pulmonary Arterial Hypertension PAH
Sponsor:
University Hospital Grenoble
Organization:
University Hospital Grenoble
Study Overview
Official Title:
Evaluation of Multidisciplinary Collaboration Care Program in Pulmonary Arterial Hypertension
Status:
COMPLETED
Status Verified Date:
2014-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ETHAP
Brief Summary:
Pulmonary arterial hypertension PAH is a severe pulmonary vascular affection which treatment has evolved in the last few years improving quality of life However adherence to treatment has not been assessed in such patients The investigators developed a collaborative care model involving clinical pharmacists in PAH The objective of this work is to evaluate the impact of such model of care on medication errors and adverse events quality of life and clinical criteria
This randomized multicentre controlled study will include approximately 100 PAH patients NYHA II to IV After inclusion patients will receive either collaborative care including consultations with specialized pharmacist and nurse or classic follow-up Each patient will be followed during 18 months from the date of inclusion
The investigators hope to show the positive impact of a collaborative care model in PAH More specifically the investigators aim to show the interest of long-term patient education to improve patient safety related to drugs but also their quality of life and have preliminary data about usual clinical criteria
This randomized multicentre controlled study will include approximately 100 PAH patients NYHA II to IV After inclusion patients will receive either collaborative care including consultations with specialized pharmacist and nurse or classic follow-up Each patient will be followed during 18 months from the date of inclusion
The investigators hope to show the positive impact of a collaborative care model in PAH More specifically the investigators aim to show the interest of long-term patient education to improve patient safety related to drugs but also their quality of life and have preliminary data about usual clinical criteria
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None